Cargando…
PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor
Background: Gliomas are aggressive tumors with various molecular and clinical characteristics and exhibit strongly resistance to radio-chemotherapy. Programmed cell death 1 ligand 2 (PD-L2) is a cell surface protein, which was reported in many cancers, modulating cancer-associated immune responses,...
Autores principales: | Wang, Zhi-liang, Li, Guan-zhang, Wang, Qiang-wei, Bao, Zhao-shi, Wang, Zheng, Zhang, Chuan-bao, Jiang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343813/ https://www.ncbi.nlm.nih.gov/pubmed/30713802 http://dx.doi.org/10.1080/2162402X.2018.1541535 |
Ejemplares similares
-
TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
por: Xie, Sidi, et al.
Publicado: (2021) -
Low expression of CDHR1 is an independent unfavorable prognostic factor in glioma
por: Wang, Haiwei, et al.
Publicado: (2021) -
Immune Cytolytic Activity Is Associated With Genetic and Clinical Properties of Glioma
por: Wang, Zhi-liang, et al.
Publicado: (2019) -
ANXA2 is correlated with the molecular features and clinical prognosis of glioma, and acts as a potential marker of immunosuppression
por: Ma, Kaiming, et al.
Publicado: (2021) -
CDCA7L promotes glioma proliferation by targeting CCND1 and predicts an unfavorable prognosis
por: Ji, Qian-Kun, et al.
Publicado: (2019)